BioGenuine

Israel-based OCON Healthcare, a specialist in uterine drug delivery, has entered into a license agreement with China’s BioGenuine. The deal grants BioGenuine exclusive marketing rights to OCON’s products in China and establishes a partnership for co-development and commercialization of new women’s health products. Deal TermsBioGenuine will pay an upfront fee…